MONICA JOHNSON: Open Payments
NPI 1679826143 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,252 in 70 payments from 11 companies in 2025. Trend: 2023 $1,223 · 2024 $934 · 2025 $1,252
Food & beverage: $1,141Education: $111
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 37 | $646 |
| Teva Pharmaceuticals USA, Inc. | 5 | $178 |
| Noven Therapeutics, LLC | 8 | $137 |
| ABBVIE INC. | 11 | $136 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Neurocrine BioSciences, Inc. | 2 | $33 |
| Alkermes, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
Products named: CAPLYTA, Xelstrym, VRAYLAR, AUSTEDO XR, INGREZZA, LYBALVI, REXULTI, HETLIOZ.
Industry payments across KY — which companies pay providers there.
